Your browser doesn't support javascript.
loading
ASO Author Reflections: Endoscopic Management is Reasonable for <2 cm Duodenal Neuroendocrine Tumors.
Tran, Catherine G; Sherman, Scott K; Howe, James R.
Affiliation
  • Tran CG; Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA. catherine-tran@uiowa.edu.
  • Sherman SK; Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
  • Howe JR; Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Ann Surg Oncol ; 29(1): 85-86, 2022 Jan.
Article in En | MEDLINE | ID: mdl-34608558
ABSTRACT
Optimal management of duodenal neuroendocrine tumors (DNETs) has not been well-defined, especially for DNETs 1-2 cm in size. Recent studies comparing endoscopic mucosal resection (EMR) and surgical resection demonstrate EMR is safe and effective for these intermediate-sized DNETs. Expert and consensus guidelines could consider updating recommendations to reflect the outcomes of EMR in DNETs and the importance of endoscopic surveillance in these patients to evaluate for local recurrence.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Duodenal Neoplasms / Endoscopic Mucosal Resection Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Duodenal Neoplasms / Endoscopic Mucosal Resection Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: United States